vimarsana.com

Latest Breaking News On - Biogen international - Page 4 : vimarsana.com

Head to Head Contrast: XOMA (NASDAQ:XOMA) & Catalyst Biosciences (NASDAQ:CBIO)

Yellow ai bolsters its Marketplace with pre-built Dynamic AI Agents to deliver faster time-to-market

Yellow ai bolsters its Marketplace with pre-built Dynamic AI Agents to deliver faster time-to-market

Australia: Achieving early generic/biosimilar market entry

New developments in Australia’s Patent Office and its courts have confirmed that overturning a patent term extension may be the “sleeper” strategy to achieve early generic/biosimilar market entry in Australia.

Federal Circuit Denies En Banc Review of Patent Written Description

Federal Circuit denied a patent owner’s request for en banc rehearing of a panel decision that invalidated a patent for lack of written description. Biogen International GMBH, Biogen MA, Inc. v. Mylan Pharmaceuticals Inc.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.